|
|
||||||||
From the Metabolism Branch and Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014
Abstract
Epstein-Barr virus (EBV)-induced activation of human peripheral blood lymphocytes was studied by the use of a reverse hemolytic plaque assay (RHPA) for the detection of immunoglobulin-producing cells. The results were compared with the effects of pokeweed mitogen (PWM) on the same cell population. Both agents caused the development of immunoglobulin-producing cells in cultures of unseparated mononuclear cells. However, B cell populations sufficiently depleted of T cells by a variety of techniques to be unresponsive to PWM showed a marked response to EBV. The reactivity of B cells to PWM could be restored by irradiated T cells, whereas there was no effect of irradiated T cells on reactivity to EBV. These data suggest that the response to EBV in contrast to the PWM response is T cell independent. Lymphocytes secreting each class of immunoglobulin (IgG, IgA, and IgM) were found in EBV-stimulated cultures of both unseparated mononuclear cells and T cell-depleted cultures, demonstrating that the response in each immunoglobulin class is also T cell independent in this system. When unseparated cell populations and B cell populations cultured at the same cell concentration were compared, the latter showed a 2- to 5-fold increased reactivity to EBV. This difference appeared to be caused primarily by an enrichment of B cells as was suggested by experiments in which the two cell populations were compared at different cell concentrations.
Footnotes
1 This work was performed when H. Kirchner was a Visiting Scientist at the National Cancer Institute. His mailing address is: Institute of Virus Research, German Cancer Research Center, 69 Heidelberg, West Germany.
This article has been cited by other articles:
![]() |
S. Vucic, W. Palmer, and D. Cros Radiculoplexopathy with conduction block caused by acute Epstein-Barr virus infection Neurology, February 8, 2005; 64(3): 530 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Sturgill, R. A. Drachtman, A. G. Ettinger, J. Rubin, and L. J. Ettinger The Influence of Epstein-Barr Virus Seropositivity on the Efficacy of Intravenous Immune Globulin in Children with Immune Thrombocytopenic Purpura Clinical Pediatrics, April 1, 1999; 38(3): 171 - 173. [PDF] |
||||
![]() |
M.A. Karajannis, M. Hummel, I. Anagnostopoulos, and H. Stein Strict Lymphotropism of Epstein-Barr Virus During Acute Infectious Mononucleosis in Nonimmunocompromised Individuals Blood, April 15, 1997; 89(8): 2856 - 2862. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Blaese, K. W. Culver, A. D. Miller, C. S. Carter, T. Fleisher, M. Clerici, G. Shearer, L. Chang, Y. Chiang, P. Tolstoshev, et al. T Lymphocyte-Directed Gene Therapy for ADA- SCID: Initial Trial Results After 4 Years Science, October 20, 1995; 270(5235): 475 - 480. [Abstract] [PDF] |
||||
![]() |
A. Muchmore and J. Decker Uromodulin: a unique 85-kilodalton immunosuppressive glycoprotein isolated from urine of pregnant women Science, August 2, 1985; 229(4712): 479 - 481. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |